Acumen Pharmaceuticals Profit Margin

Acumen Pharmaceuticals (ABOS) currently reports a profit margin of 125862.22% as of March 2026. That is above the Healthcare sector average of 15.58%. Use the charts on this page to explore Acumen Pharmaceuticals's profit margin history and peer comparisons.

Acumen Pharmaceuticals's profit margin of 125862.22% is higher than the Healthcare sector average of 15.58%. That is roughly 807535.8% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Acumen Pharmaceuticals's current 125862.22% should be judged against Healthcare norms (sector average: 15.58%) and against ABOS's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 125862.22%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 15.58%. From there, open related valuation or income-statement pages for Acumen Pharmaceuticals, and consider following ABOS for alerts when major investors trade the stock.

Acumen Pharmaceuticals is classified in the Healthcare sector. On profit margin, it currently shows 125862.22% versus a sector average near 15.58%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ABOS with unrelated industries.